Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2015

Entresto(Sacubitril/Valsartan)Novartis AG logoNVS

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Novartis AG

$4.02B

Medicare cost, 2024

Medicare drug plans spent $4.0 billion on Entresto (sacubitril/valsartan) in 2024, for 3.9 million prescriptions and refills filled by 795,090 patients. It ranks 11th among all drugs by Medicare drug plan spending. Spending rose 17% from 2023 to 2024. Florida accounts for the most spending ($359.1 million, 9% of the total).

Medicare cost, 2024

$4.02B

+17.2% from 2023

Prescriptions

3.9M

$1,031.18 per claim

Patients

795K

216,604 prescribers

Total spending, 2024

$4.02B

$5,055.16 per patient

Questions and answers

How much does Medicare spend on Entresto?

Medicare prescription drug plans paid $4.02B for Entresto in 2024, for 3,897,762 prescriptions and refills to 795,090 patients (up 17.2% from 2023). The average cost per claim was $1,031.18.

Which state spends the most on Entresto?

Florida had the highest Medicare cost for Entresto in 2024: $359.1M for 330,367 claims, followed by California ($355.1M).

Who prescribes Entresto the most?

Haroutioun D Mesrobian, cardiology in Glendale, CA, had the highest Medicare cost for Entresto in 2024: 2,531 claims costing $1.8M.

Who makes Entresto?

Entresto is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Entresto was $4.02B in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Entresto, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Haroutioun D Mesrobian Glendale, CACardiology2,531301$1.8M
David H Lau New York, NYCardiology1,960294$1.6M
Glenn H Herrington Wilmington, NCPharmacist836277$1.4M
Mohamed H Khan Redding, CAInterventional Cardiology927282$1.4M
John T Funai Lihue, HICardiology844257$1.3M
Sohaib Tariq Imperial, CACardiology1,614437$1.3M
Chetan Bhardwaj Peoria, ILCardiology1,058243$1.2M
Robert D Miles Jr. Thomasville, GACardiology1,444283$1.2M
Kenneth M Burnham Mobile, ALAdvanced Heart Failure and Transplant Cardiology1,133264$1.2M
Kashyap B Choksi Thomasville, GACardiology1,542318$1.2M
Warren K Stribling Nashville, TNAdvanced Heart Failure and Transplant Cardiology1,006257$1.1M
Dalton S McLean Greensboro, NCAdvanced Heart Failure and Transplant Cardiology1,110238$1.1M
Robert A Gordon Evanston, ILAdvanced Heart Failure and Transplant Cardiology824219$1.1M
Ugochukwu O Egolum Gainesville, GAAdvanced Heart Failure and Transplant Cardiology912246$1.1M
Andrew Darlington Fayetteville, GAAdvanced Heart Failure and Transplant Cardiology1,014227$1.1M
Rajeev R Fernando Sioux Falls, SDCardiology913220$1.1M
Dannis E Hood Ringgold, GAInterventional Cardiology1,151280$1.1M
Humberto C Machado Jr. Coral Gables, FLCardiology1,152339$1.1M
Giancarlo Acosta Gainesville, GAAdvanced Heart Failure and Transplant Cardiology933251$1.0M
Ataul M Qureshi Canton, OHCardiology927219$1.0M
Tonya D Baker Kingsport, TNNurse Practitioner1,161256$1.0M
Ali M Nasur El Paso, TXCardiology697243$1.0M
Catherine N Marti Athens, GACardiology774181$1.0M
Samir A Hadeed Johnstown, PACardiology1,016211$994K
Munir S Janmohamed Sacramento, CAAdvanced Heart Failure and Transplant Cardiology808200$989K

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022158,5102,527,114520,741$2.49B
2023190,7533,198,752663,207$3.43B
2024216,6043,897,762795,090$4.02B

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
NovartisNVS logoNVS3,898,804$4.02B

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
15
RxNorm concept IDs
1656340, 1656346, 1656349, 1656351, 1656354
Application numbers
NDA207620, NDA218591

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube